175 related articles for article (PubMed ID: 15773062)
1. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution.
Raman C; Berkland C; Kim K; Pack DW
J Control Release; 2005 Mar; 103(1):149-58. PubMed ID: 15773062
[TBL] [Abstract][Full Text] [Related]
2. PLG microsphere size controls drug release rate through several competing factors.
Berkland C; Kim K; Pack DW
Pharm Res; 2003 Jul; 20(7):1055-62. PubMed ID: 12880292
[TBL] [Abstract][Full Text] [Related]
3. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
[TBL] [Abstract][Full Text] [Related]
4. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
5. Precise control of PLG microsphere size provides enhanced control of drug release rate.
Berkland C; King M; Cox A; Kim K; Pack DW
J Control Release; 2002 Jul; 82(1):137-47. PubMed ID: 12106984
[TBL] [Abstract][Full Text] [Related]
6. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions.
Berkland C; Kim K; Pack DW
J Control Release; 2001 May; 73(1):59-74. PubMed ID: 11337060
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
[TBL] [Abstract][Full Text] [Related]
10. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.
Pollauf EJ; Berkland C; Kim KK; Pack DW
Int J Pharm; 2005 Sep; 301(1-2):294-303. PubMed ID: 16051452
[TBL] [Abstract][Full Text] [Related]
11. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine.
Sturesson C; Degling Wikingsson L
J Control Release; 2000 Sep; 68(3):441-50. PubMed ID: 10974398
[TBL] [Abstract][Full Text] [Related]
12. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
13. About mean diameter and size distributions of poly(lactide-co-glycolide) (PLG) microspheres.
Berchane NS; Jebrail FF; Carson KH; Rice-Ficht AC; Andrews MJ
J Microencapsul; 2006 Aug; 23(5):539-52. PubMed ID: 16980275
[TBL] [Abstract][Full Text] [Related]
14. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
[TBL] [Abstract][Full Text] [Related]
15. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
[TBL] [Abstract][Full Text] [Related]
16. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.
Tracy MA; Ward KL; Firouzabadian L; Wang Y; Dong N; Qian R; Zhang Y
Biomaterials; 1999 Jun; 20(11):1057-62. PubMed ID: 10378806
[TBL] [Abstract][Full Text] [Related]
18. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
19. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
[TBL] [Abstract][Full Text] [Related]
20. Measurement of protein diffusion through poly(D,L-lactide-Co-glycolide).
Fredenberg S; Reslow M; Axelsson A
Pharm Dev Technol; 2005; 10(2):299-307. PubMed ID: 15926679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
